Heart Attack

View All

polypills
Polypills: Can they offer a potential approach to treat CVDs?

Cardiovascular disease (CVD), such as heart attack and stroke, is a leading cause of deaths and hampering the quality of life in the US. Moreover, the disease will continue to afflict the lives of the people by 2020.  High blood pressure, hypertension and high cholesterol are the major comorbidities of CVD,...

Find More

Delveinsight
A Glimpse of the Anticoagulants Therapy Market; Major Players

VTE therapeutics & Atrial Fibrillation market was worth USD 4 billion in 2014 and USD 7.86 billion respectively. The VTE therapeutic market is expected to reach USD 5.5 billion by 2018 with a Compound Annual Growth Rate (CAGR) of 8.29% and Atrial Fibrillation market will reach on its peak value USD 13.28 billi...

Find More